Evidence map›Paper›PMID 42488153›Full record

ArticleHeart rhythm O22026

Impaired left atrial strain is associated with new-onset atrial fibrillation and adverse clinical outcomes in primary care patients.

Shani Dahan, Jason Sherer, Ygal Plakht, Rasmus B Sindre, Dana Cramariuc, Shaan S Khurshid, Mostafa A Al-Alusi, Patrick T Ellinor, Steven A Lubitz, Jonathan J Passeri and 3 more

Abstract read
In one paragraph

Article in Heart rhythm O2, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Shani DahanDivision of Cardiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Jason ShererDivision of Cardiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Ygal PlakhtFaculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel.
Rasmus B SindreDepartment of Clinical Science, University of Bergen, Bergen, Norway.
Dana CramariucDepartment of Clinical Science, University of Bergen, Bergen, Norway.
Shaan S KhurshidCardiovascular Research Center, Mass General Brigham, Boston, Massachusetts.
Mostafa A Al-AlusiCardiovascular Research Center, Mass General Brigham, Boston, Massachusetts.
Patrick T EllinorDivision of Cardiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Steven A LubitzCardiovascular Research Center, Mass General Brigham, Boston, Massachusetts.
Jonathan J PasseriDivision of Cardiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Evin YucelDivision of Cardiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Michael H PicardDivision of Cardiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Judy HungDivision of Cardiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

Funding

REVISED CAROL ACT IIU01HL088942 · NHLBI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI GELIJNS, ANNE CHRISTINE, MOSKOWITZ, ALAN J · 2007 to 2025
$122.6M
IDENTIFICATION OF COMMON GENETIC VARIANTS FOR ATRIAL FIBRILLATION AND PR INTERVALR01HL092577 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI BENJAMIN, EMELIA J., ELLINOR, PATRICK THOMAS · 2009 to 2025
$20.6M
Using Electrocardiogram Genetics to Inform Arrhythmia RiskR01HL157635 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI ELLINOR, PATRICK THOMAS, MIRSHAHI, TOORAJ · 2022 to 2025
$2.9M
Polymer Therapy for Ischemic Mitral RegurgitationR01HL092101 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI HUNG, JUDY W · 2009 to 2013
$2.1M
From genetic basis to mechanisms for Heart FailureR01HL177209 · NHLBI · BROAD INSTITUTE, INC. · PI Patrick Thomas Ellinor, Ling Xiao · 2025 to 2026
$1.6M
Electrocardiogram-based deep learning and decision analysis to improve atrial fibrillation risk estimationK23HL169839 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI Shaan Khurshid · 2023 to 2026
$860k
NHLBI NIH HHS K23 HL169839NHLBI NIH HHS R01 HL092101NHLBI NIH HHS R01 HL092577NHLBI NIH HHS R01 HL157635NHLBI NIH HHS R01 HL177209NHLBI NIH HHS U01 HL088942
6 · The paper itself

Abstract

Background: Atrial fibrillation (AF) is linked to adverse left atrial (LA) remodeling, including fibrosis and mechanical dysfunction. LA strain is an imaging marker of atrial function that may improve risk stratification for AF, but its predictive and prognostic value in the primary care population remains unclear. Objective: This study aimed to evaluate whether LA strain is associated with new-onset AF and adverse clinical outcomes after AF diagnosis. Methods: We performed a 2-part study within a longitudinal primary care cohort (2001-2019). In a nested case-control analysis, 216 patients with new-onset AF were compared with 216 age- and sex-matched controls. LA strain parameters, including peak atrial longitudinal strain (PALS), peak atrial contractile strain, and LA conduit strain (LACS), were measured using speckle-tracking echocardiography before AF onset. In 127 patients with new-onset AF, Cox models examined associations between LA strain and all-cause mortality, stroke, myocardial infarction, and heart failure hospitalization. Results: Lower PALS and LACS were independently associated with more than 3-fold higher odds of AF (both Conclusion: In a primary care cohort, impaired LA strain was independently associated with new-onset AF and adverse outcomes after AF diagnosis, supporting its role in AF risk stratification.

Indexed as

Atrial fibrillationClinical outcomesEchocardiographyLeft atrial strainRisk stratification

Identifiers

PMID42488153
PMCPMC13389975

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.